3-(2-bromo-3-fluorophenyl)-7-tert-butyl-2-(2,6-dimethylphenyl)-[1]benzofuro[2,3-e]benzimidazole;ethane
C33H32BrFN2O — CID 155714752
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-(2-bromo-3-fluorophenyl)-7-tert-butyl-2-(2,6-dimethylphenyl)-[1]benzofuro[2,3-e]benzimidazole;ethane
3-(2-bromo-3-fluorophenyl)-7-tert-butyl-2-(2,6-dimethylphenyl)-[1]benzofuro[2,3-e]benzimidazole;ethane (PubChem CID 155714752) has the molecular formula C33H32BrFN2O and a molecular weight of 571.53 g/mol. Its IUPAC name is 3-(2-bromo-3-fluorophenyl)-7-tert-butyl-2-(2,6-dimethylphenyl)-[1]benzofuro[2,3-e]benzimidazole;ethane.
Molecular Properties
| Compound Name | 3-(2-bromo-3-fluorophenyl)-7-tert-butyl-2-(2,6-dimethylphenyl)-[1]benzofuro[2,3-e]benzimidazole;ethane |
|---|---|
| PubChem CID | 155714752 |
| Molecular Formula | C33H32BrFN2O |
| Molecular Weight | 571.53 g/mol |
| Exact Mass | 570.17 |
| IUPAC Name | 3-(2-bromo-3-fluorophenyl)-7-tert-butyl-2-(2,6-dimethylphenyl)-[1]benzofuro[2,3-e]benzimidazole;ethane |
| SMILES | CC.Cc1cccc(C)c1-c1nc2c3oc4ccc(C(C)(C)C)cc4c3ccc2n1-c1cccc(F)c1Br |
| InChI | InChI=1S/C31H26BrFN2O.C2H6/c1-17-8-6-9-18(2)26(17)30-34-28-24(35(30)23-11-7-10-22(33)27(23)32)14-13-20-21-16-19(31(3,4)5)12-15-25(21)36-29(20)28;1-2/h6-16H,1-5H3;1-2H3 |
| InChIKey | GFPMDTOLSWOYLQ-UHFFFAOYSA-N |
| XLogP | 10.43 |
| TPSA | 30.96 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 2 |
| Heavy Atoms | 38 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 571.53 |
| LogP ≤ 5 | 10.43 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 3 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155714752 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.